The observed increase in levels of SERPINA1 and SERPINA3 might therefore partly reflect the more stable, chemoattractant, pro-inflammatory cleaved forms, rather than the short-lived tissue-protective proteins in severe COVID-19. This evidence concerns the gene SERPINA1 and COVID-19.